Friday, April 09, 2004

Pop this pill and double your body's good cholesterol!

The drug torcetrapib, made by Pfizer, significantly increased levels of HDL in patients with low levels of this "good" cholesterol, whether or not they were also being treated with the cholesterol-lowering drug atorvastatin (Lipitor). The combination therapy used in the trial proved so effective that, among those patients who received the highest dosages of both drugs, HDL cholesterol levels were increased by more than 100 percent.

A low level of HDL cholesterol is the most common lipid abnormality observed in patients with known coronary heart disease.

No comments: